Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $130,965 - $147,719
-2,373 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$50.53 - $62.98 $119,907 - $149,451
2,373 New
2,373 $131,000
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $141,950 - $163,413
-2,369 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$59.94 - $65.35 $119 - $130
2 Added 0.08%
2,369 $145,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $130,729 - $150,872
2,367
2,367 $151,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Landaas & CO Portfolio

Follow Landaas & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

News

Stay updated on Landaas & CO with notifications on news.